Page 1,248«..1020..1,2471,2481,2491,250..1,2601,270..»

The Heart of the Matter: Leveraging Advances in Cardiac Biology to Innovate Gene-Based Therapies for Heart Failure – Physician’s Weekly

Posted: Published on November 15th, 2019

Heart failure (HF) is the most frequent cardiovascular diagnosis and exacts significant health and financial costs around the globe. It is estimated that at least 26 million people worldwide are living with HF, including nearly 6 million in the United States.1, 2 One in nine U.S. deaths in 2009 included heart failure as a contributing cause and about 50 percent of people in the U.S. Continue reading

Posted in Cardiac Regeneration | Comments Off on The Heart of the Matter: Leveraging Advances in Cardiac Biology to Innovate Gene-Based Therapies for Heart Failure – Physician’s Weekly

Global Regenerative Medicines Market Demand Analysis & Opportunity Evaluation Report 2019-2027 with Focus on U.S. & Europe -…

Posted: Published on November 15th, 2019

DUBLIN--(BUSINESS WIRE)--The "Global, U.S. & Europe Regenerative Medicines Market Demand Analysis & Opportunity Evaluation, 2019-2027" report has been added to ResearchAndMarkets.com's offering Continue reading

Posted in Cardiac Regeneration | Comments Off on Global Regenerative Medicines Market Demand Analysis & Opportunity Evaluation Report 2019-2027 with Focus on U.S. & Europe -…

Halting the progression of multiple sclerosis by blocking harmful B cells – FierceBiotech

Posted: Published on November 15th, 2019

The blood-brain barrier in healthy people is a powerful shield that protects neurons from harmful invaders. But in people with multiple sclerosis (MS), that shield malfunctions, allowing B cells from the immune system to pass into the brain and destroy healthy tissues. Scientists at the University of Montreal Hospital Research Centre (CRCHUM) have identified a new target that they suggest could be exploited to slow down the flow of B cells into the brains of people with MS. Continue reading

Posted in MS Treatment | Comments Off on Halting the progression of multiple sclerosis by blocking harmful B cells – FierceBiotech

Sports Announcer Dave Johnson Talks About Fighting Multiple Sclerosis, Which His Mother Had – NBC4 Washington

Posted: Published on November 15th, 2019

Dave Johnson, an unmistakable voice of D.C. sports radio and a beloved member of the News4 family, is battling multiple sclerosis, the same disease his mother struggled with when he was a child. The radio voice of the Washington Wizards for more than 20 years, Johnson is known for his sense of humor and strong work ethic. Continue reading

Posted in MS Treatment | Comments Off on Sports Announcer Dave Johnson Talks About Fighting Multiple Sclerosis, Which His Mother Had – NBC4 Washington

Stratford Group Looks To Give Wing The ‘Coady’ Treatment – CapeNews.net

Posted: Published on November 15th, 2019

A company that renovated the former Kempton J. Coady School in Bourne Village into affordable housing for people over 55 is looking to do the same to the former Henry T. Continue reading

Posted in MS Treatment | Comments Off on Stratford Group Looks To Give Wing The ‘Coady’ Treatment – CapeNews.net

Novartis’ Mayzent and EMD Serono’s Mavenclad Look to Dethrone Genentech’s Ocrevus in the Expanding Patient Segment of Active Secondary Progressive…

Posted: Published on November 15th, 2019

EXTON, Pa., Nov. 14, 2019 /PRNewswire/ --Following the recent March approvals of Novartis' Mayzent and EMD Serono's Mavenclad, Genentech's Ocrevus continues to dominate neurologists' stated preference across the three segments of patients with progressive forms of multiple sclerosis (MS): active secondary progressive MS (SPMS), not active SPMS, and primary progressive MS (PPMS). Consistent with perception, data from 751 charts of disease-modifying therapy (DMT)-treated patients with a progressive form of MS (PfMS) provided by 157 neurologists in Spherix's RealWorld Dynamix: Progressive Forms of Multiple Sclerosis (US)service confirm that Ocrevus remains the most prescribed DMT for active SPMS and PPMS patients, chosen primarily because of a desire for reduced inflammatory disease activity or delay in disability progression, respectively. Continue reading

Posted in MS Treatment | Comments Off on Novartis’ Mayzent and EMD Serono’s Mavenclad Look to Dethrone Genentech’s Ocrevus in the Expanding Patient Segment of Active Secondary Progressive…

How well find an effective treatment for Alzheimers – Quartz

Posted: Published on November 15th, 2019

Alzheimers, one of the direst health threats in the US, is not showing signs of slowing down. Continue reading

Posted in MS Treatment | Comments Off on How well find an effective treatment for Alzheimers – Quartz

UK National Health Service approves two CBD drugs for the first time ever – ZME Science

Posted: Published on November 15th, 2019

The two drugs which will target epilepsy and multiple sclerosis have been approved for use by the National Health Service (NHS). CBD is all the rage right now but for all the hype and products that are popping up, there is surprisingly little research to back it all up. Most of the studies that have been made were not on humans or did not have a thorough and convincing design Continue reading

Posted in MS Treatment | Comments Off on UK National Health Service approves two CBD drugs for the first time ever – ZME Science

Selma Blair Posts Eye-Opening Throwback From Before MS Diagnosis: ‘Already Exhausting and Confusing’ – PopCulture.com

Posted: Published on November 15th, 2019

Before Selma Blair was diagnosed with multiple sclerosis, she was still exhausted and confused by symptoms from her deteriorating health. The actress, 47, shared a video Friday that she took before she knew she had MS, although she said she was already getting significant help from her friend Bonny Burke to get through the day. Continue reading

Posted in MS Treatment | Comments Off on Selma Blair Posts Eye-Opening Throwback From Before MS Diagnosis: ‘Already Exhausting and Confusing’ – PopCulture.com

‘I don’t want to go blind on a waiting list’ – BBC News

Posted: Published on November 15th, 2019

Media playback is unsupported on your device A Londonderry woman on a cataract surgery waiting list has said she fears she will go blind before getting treatment. Dianne Thomas, 49, was diagnosed with the eye condition in February and referred to an ophthalmic specialist. Continue reading

Posted in MS Treatment | Comments Off on ‘I don’t want to go blind on a waiting list’ – BBC News

Page 1,248«..1020..1,2471,2481,2491,250..1,2601,270..»